The hedge fund’s shares of CHS are valued at $17.36 million.
CHS’ stock price has declined 40.9 percent since the end of January and is trending downward, according to the report.
More articles on healthcare finance:
UMC approves debt repayment plan for bankrupt children’s hospital
UPMC gets financial boost from insurance division
AHA: Proposal to reduce Medicare appeals backlog won’t solve problem
